NRD
AMSF icon

Nebula Research & Development’s AMERISAFE AMSF Stock Holding History

Nebula Research & Development’s Portfolio AMSF Stock Details AMSF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-22,540
Closed -$986K – 53
2025
Q2 		$986K Buy
22,540
+12,916
+134% +$609K 0.08% 405
2025
Q1 		$506K Sell
9,624
-232
-2% -$11.8K 0.05% 609
2024
Q4 		$508K Sell
9,856
-525
-5% -$28.4K 0.06% 552
2024
Q3 		$502K Sell
10,381
-12,002
-54% -$571K 0.06% 552
2024
Q2 		$982K Buy
+22,383
New +$1.03M 0.16% 220

Other funds holding AMSF

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Nebula Research & Development's AMSF Position: Q3 2025 in Review

Nebula Research & Development sold out of AMERISAFE (AMSF) in Q3 2025, closing a stake of 22,540 shares — an estimated $986K sold.

Nebula Research & Development first reported a position in AMSF in Q2 2024 and held it in 5 quarters. The position peaked at $986K in Q2 2025. 196 funds tracked by Wall St. Rank hold AMSF as of Q3 2025.

  • Nebula Research & Development reported no remaining AMERISAFE position as of Q3 2025 after selling out during the quarter.
  • Nebula Research & Development sold 22,540 AMERISAFE shares in Q3 2025, an estimated $986K.
  • Nebula Research & Development first reported a position in AMERISAFE in Q2 2024 and held it in 5 quarters.
  • Nebula Research & Development's AMERISAFE position peaked at $986K in Q2 2025.
  • 196 funds tracked by Wall St. Rank held AMERISAFE as of Q3 2025.

Based on Nebula Research & Development's 13F filing for Q3 2025.